Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Rheumatology (Oxford, England)|December 13, 2016
Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathiesAhmed A El-Zayadi, Elena A Jones, Sarah M Churchman, et al.
Journal of Clinical Immunology|December 21, 2019
Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS DeficiencyHassan Abolhassani, Yasser M El-Sherbiny, Gururaj Arumugakani, et al.
Annals of the Rheumatic Diseases|June 23, 2018
Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon statusMd Yuzaiful Md Yusof, Antonios Psarras, Yasser M El-Sherbiny, et al.
Annals of the Rheumatic Diseases|February 5, 2021
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of sclerodermaRebecca L Ross, Clarissa Corinaldesi, Gemma Migneco, et al.
Advances in Biochemical Engineering/Biotechnology|October 26, 2023
Imprinted Polymers on the Route to Plastibodies for Biomacromolecules (MIPs), Viruses (VIPs), and Cells (CIPs)Xiaorong Zhang, Aysu Yarman, Mahdien Bagheri, et al.
Molecular Immunology|December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytesJehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
Cancer Research|September 19, 2007
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cellsYasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, et al.
The Egyptian Journal of Immunology|June 1, 2006
Expression of HLA-G in cancer bladderFarha A El-Chennawi, Fatma A Auf, Amany M El-Diasty, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 6, 2019
B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus ErythematosusYasser M El-Sherbiny, Md Yuzaiful Md Yusof, Antonios Psarras, et al.
Nature Immunology|January 16, 2019
The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulumSonal Srikanth, Jin Seok Woo, Beibei Wu, et al.
Pageof 27